| |
New perspectives of radiotherapy
Chair: Roberto Orecchia
Rapporteur: Giovanni Ivaldi |
| 08.15 |
Accelerated courses of external radiotherapy – John Dewar |
| 08.30 |
Partial breast irradiation - Frank Vicini |
| 08.45 |
Intraoperative radiotherapy – Roberto
Orecchia |
| 09.00 |
The potential use of proton beam in
the treatment of breast cancer - Alphonse G. Taghian |
| 09.15 |
Discussion |
| 09.25 |
Spotlight:
St. Gallen 2009: Views and News – Alan S. Coates |
| |
Endocrine treatments & more
Chair: Eric Winer
Rapporteur: Rosalba Torrisi |
| 09.45 |
Tailoring endocrine therapies for premenopausal
women – Ann H. Partridge |
| 10.05 |
Advances in endocrine therapies for
postmenopausal women – Ian E. Smith |
| 10.25 |
Coffee Break |
| 10.55 |
The challenge of treating endocrine
responsive disease: overcoming resistance
and choosing additional targets – Antonio C. Wolff |
| 11.15 |
Discussion |
| 11.25 |
Spotlight:
New strategies for better treatment
outcome: combining and sequencing
old and new therapies - Harold J.
Burstein |
| 11.45 |
The Milan Breast Cancer
Observatory: Innovation and care
in the next 12 months
Participants: Alan
S. Coates - Viviana Galimberti - Aron Goldhirsch - Roberto Orecchia -
Virgilio Sacchini - Giuseppe Viale
Chair: Alberto Costa |
| 12.45 |
Lunch |
| |
Targeted treatments
Chair: Harold Burstein
Rapporteur: Emilia Montagna |
| 13.45 |
A basket full of new targeted treatments:
How useful? – Eric Winer |
| 14.05 |
Beyond trastuzumab and bevacizumab:
other monoclonal antibodies
with potential efficacy – Giuseppe
Curigliano |
| 14.25 |
Breast cancer with no apparent targets:“the triple negative” – Angelo Di Leo |
| 14.45 |
Discussion |
| 15.00 |
Coffee Break |
| |
Preoperative systemic (cytotoxic
and targeted) therapies
Chair: Aron Goldhirsch
Rapporteur: Alessandra Balduzzi |
| 15.30 |
Is it important to insist on shrinking
large operable tumors ? - Günter von
Minckwitz |
| 15.50 |
Preoperative therapies – the opportunity
for understanding early effects of
breast cancer treatments – Christos
Sotiriou |
| 16.10 |
Endocrine responsiveness and the
choice of neo-adjuvant treatment – Marco Colleoni |
| 16.30 |
Discussion |
| 16.45 |
Special Spotlight:
Minimal burden to breast cancers:
how to approach? - Massimo
Cristofanilli
Discussion: Franco Nolè |
| 17.10 |
Closing remarks |
HOME PAGE
Wed, 17 june 2009
Additional Activities